SREBF1 and metabolic dysfunction-associated steatotic liver disease: Tanshinone IIA, a bioactive phytochemical from Salvia miltiorrhiza Bunge, attenuates lipid accumulation by modulating the LXRα–SREBP1 pathway to treat MASLD [118].